[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.159.27. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 556
Citations 0
Invited Commentary
May 2016

Surgery for Stage IV Breast CancerDomestic and International Disparities

Author Affiliations
  • 1University of Michigan, Comprehensive Cancer Center, Ann Arbor
JAMA Surg. 2016;151(5):431. doi:10.1001/jamasurg.2015.4507

Advances in systemic therapy have improved survival of women with metastatic breast cancer. The Thomas et al1 analysis of Surveillance, Epidemiology, and End Results (SEER) data supports the concept that surgery may contribute to an outcome advantage by reducing the total body burden of disease. While this study’s overarching focus is indeed meaningful, it is also informative to place results from this report in the context of conversations regarding breast cancer disparities associated with racial/ethnic identity, young age, and country of origin.

First Page Preview View Large
First page PDF preview
First page PDF preview
×